Denied

No. 22-671

Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd., et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

Reply of petitioner Novartis Pharmaceuticals Corporation filed. (Distributed)

Motion to extend the time to file a response is granted and the time is extended to and including March 3, 2023.

Motion to extend the time to file a response from February 21, 2023 to March 3, 2023, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due February 21, 2023)

Application (22A507) granted by The Chief Justice extending the time to file until January 18, 2023.

Application (22A507) to extend the time to file a petition for a writ of certiorari from December 19, 2022 to January 18, 2023, submitted to The Chief Justice.

Parties

Novartis Pharmaceuticals Corporation, Petitioner, represented by Deanne Elizabeth Maynard

HEC Pharm Co., Ltd., HEC Pharm USA Inc., Respondent, represented by Peter K. Stris

 
Last updated: February 23, 2024